Osiris Therapeutics, Inc. Announces Receipt Of $15 Million Milestone Payment For Prochymal

Osiris Announces Receipt of $15 Million Milestone Payment for Prochymal COLUMBIA, Md.-- -- Osiris Therapeutics, Inc. , the leading stem cell company focused on developing and marketing products to treat conditions in orthopedic, sports medicine and wound care markets announced that it has received a $15 million milestone payment from Mesoblast for ... (more)

http://www.biospace.com/news_story.aspx?StoryID=319231&full=1